These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 6417282

  • 1. Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degenerations.
    Sobue I, Takayanagi T, Nakanishi T, Tsubaki T, Uono M, Kinoshita M, Igata A, Miyazaki M, Yoshida M, Ando K.
    J Neurol Sci; 1983 Oct; 61(2):235-48. PubMed ID: 6417282
    [Abstract] [Full Text] [Related]

  • 2. Acute and chronic effects of thyrotropin-releasing hormone (TRH) on stabilogram in spinocerebellar degenerations.
    Yoshida M, Nakanishi T, Komatsu Y.
    Tohoku J Exp Med; 1986 Mar; 148(3):327-31. PubMed ID: 3085285
    [Abstract] [Full Text] [Related]

  • 3. [Chronic experimentation with TRH administered intramuscularly in spinocerebellar degeneration. Double-blind cross-over study in 30 subjects].
    Filla A, De Michele G, Di Martino L, Mengano A, Iorio L, Maggio MA, Campanella G.
    Riv Neurol; 1989 Mar; 59(2):83-8. PubMed ID: 2505370
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy of TRH-T for spinocerebellar degeneration--the relation between clinical features and effect of TRH therapy].
    Waragai M, Ogawara K, Takaya Y, Hayashi M.
    Rinsho Shinkeigaku; 1997 Jul; 37(7):587-94. PubMed ID: 9396355
    [Abstract] [Full Text] [Related]

  • 5. Motor disabilities and effects of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration.
    Kimura I, Ohtomo H, Kogure K.
    Tohoku J Exp Med; 1983 Apr; 139(4):331-7. PubMed ID: 6408760
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of rovatirelin in patients with cerebellar ataxia: two randomised double-blind placebo-controlled phase 3 trials.
    Nishizawa M, Onodera O, Hirakawa A, Shimizu Y, Yamada M, Rovatirelin Study Group.
    J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):254-262. PubMed ID: 31937586
    [Abstract] [Full Text] [Related]

  • 9. Effects of tartrate thyrotropin-releasing hormone treatment on serum thyrotropin, free triiodothyronine, free thyroxine and prolactin levels in patients with spinocerebellar degeneration.
    Merola B, Colao A, Di Renzo G, Filla A, Campanella G, Lombardi G.
    Horm Res; 1992 Mar; 38(3-4):160-3. PubMed ID: 1306848
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the effect of thyrotropin releasing hormone (TRH) on regional cerebral blood flow in spinocerebellar degeneration using 3DSRT.
    Kimura N, Kumamoto T, Masuda T, Nomura Y, Hanaoka T, Hazama Y, Okazaki T, Arakawa R.
    J Neurol Sci; 2009 Jun 15; 281(1-2):93-8. PubMed ID: 19286195
    [Abstract] [Full Text] [Related]

  • 11. [Spinocerebellar degenerations].
    Sobue I.
    Nihon Naika Gakkai Zasshi; 1984 Oct 15; 73(10):1415-31. PubMed ID: 6440937
    [No Abstract] [Full Text] [Related]

  • 12. Spinocerebellar degenerations--clinical aspects and new treatment of ataxia.
    Sobue I.
    Jpn J Med; 1985 Feb 15; 24(1):62-7. PubMed ID: 3923240
    [No Abstract] [Full Text] [Related]

  • 13. Thyrotropin-releasing hormone (TRH) inchronic schizophrenia. A controlled study.
    Lindström LH, Gunne LM, Ost LG, Persson E.
    Acta Psychiatr Scand; 1977 Jan 15; 55(1):74-80. PubMed ID: 402794
    [Abstract] [Full Text] [Related]

  • 14. [The effect of the thyrotropin releasing hormone (TRH) on the motor speech disorder in spinocerebellar degeneration].
    Nozaki Y, Hashimoto M, Ohnishi A, Murai Y, Ogata H, Makishima K.
    J UOEH; 1992 Jun 01; 14(2):173-83. PubMed ID: 1621012
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, placebo-controlled trial of TRH in amyotrophic lateral sclerosis.
    Caroscio JT, Cohen JA, Zawodniak J, Takai V, Shapiro A, Blaustein S, Mulvihill MN, Loucas SP, Gudesblatt M, Rube D.
    Neurology; 1986 Feb 01; 36(2):141-5. PubMed ID: 3080693
    [Abstract] [Full Text] [Related]

  • 16. [Clinical studies of spinocerebellar degeneration].
    Sohue I.
    Nihon Naika Gakkai Zasshi; 1984 Feb 01; 73(2):175-8. PubMed ID: 6427370
    [No Abstract] [Full Text] [Related]

  • 17. The long loop reflex in spinocerebellar degeneration and motor neuron disease--its changes with TRH therapy.
    Touge T, Takeuchi H, Yamada A, Miki H, Nishioka M.
    Electromyogr Clin Neurophysiol; 1990 Feb 01; 30(3):131-40. PubMed ID: 2112456
    [Abstract] [Full Text] [Related]

  • 18. Amyotrophic lateral sclerosis: effects of acute intravenous and chronic subcutaneous administration of thyrotropin-releasing hormone in controlled trials.
    Mitsumoto H, Salgado ED, Negroski D, Hanson MR, Salanga VD, Wilber JF, Wilbourn AJ, Breuer AC, Leatherman J.
    Neurology; 1986 Feb 01; 36(2):152-9. PubMed ID: 3080695
    [Abstract] [Full Text] [Related]

  • 19. Controlled trial of thyrotropin releasing hormone in amyotrophic lateral sclerosis.
    Brooke MH, Florence JM, Heller SL, Kaiser KK, Phillips D, Gruber A, Babcock D, Miller JP.
    Neurology; 1986 Feb 01; 36(2):146-51. PubMed ID: 3080694
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the effects of thyrotropin releasing hormone (TRH) therapy on regional cerebral blood flow in the cerebellar variant of multiple system atrophy using 3DSRT.
    Kimura N, Kumamoto T, Masuda T, Nomura Y, Hanaoka T, Hazama Y, Okazaki T.
    J Neuroimaging; 2011 Apr 01; 21(2):132-7. PubMed ID: 19674246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.